Meanwhile, microdose GLP-1s kickstart the action-motivation flywheel, enabling early successes by limiting food noise and creating space for healthier habits
As more consumers eat less per occasion, avoid indulgent items, and prioritize protein, QSR operators need to move beyond a model built primarily on calorie density, upsizing, and impulse add-ons
Locking in compounded semaglutide at under $150 a month is a great deal considering most other providers are charging $250 and up
As the newest addition to incretin-based drugs, tirzepatide harbors the potential to counteract most of the pathogenetic mechanisms underpinning CKD in T2D displaying unprecedented features in terms of glucose and weight lowering, accompanied by promotion of insulin sensitivity, control of SBP, dyslipidemia, and biomarkers of inflammation and endothelial dysfunction
In this context, it has been demonstrated that treatments with either a GLP1/Estrogen (GLP1/E) conjugate, a unimolecular GLP1/GIP (gastric inhibitory peptide) dual agonist, or a GLP1/GIP/Glucagon triagonist, markedly reduced body weight and improved diabetic complications, including hyperinsulinemia, in preclinical models of obesity in males 33,34,35
To test the system, I entered exaggerated numbers
